While the title of this section is Men’s Health, we’re focusing on prostate cancer since it is the third most common cause of cancer death in American men and the most common cause of death from cancer in men over 75 years old. It affect
Read More
Breath tests are increasingly being explored and implemented in clinical diagnosis, offering a non-invasive means to detect a variety of conditions like blood cancer, lung disease, lower respiratory tract infections, and gastroparesis.
Read More
Natera has received two new FDA Breakthrough Device Designations for its personalized Signatera ctDNA test.
Read More
LG AI Research has launched EXAONE Path 2.0, a cutting-edge precision medical AI model that predicts gene mutations and biological markers.
Read More
Quest Diagnostics is partnering with MD Anderson Cancer Center to develop a lab-based blood test for cancer that uses protein biomarkers.
Read More